apoC1 Double Nickase Plasmid (h): sc-403713-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- apoC1 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- apoC1 Double Nickase Plasmid (h) and apoC1 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting APOC1. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
apoC1 Double Nickase Plasmid (h) | sc-403713-NIC | 20 µg | $410.00 | |||
apoC1 Double Nickase Plasmid (h2) | sc-403713-NIC-2 | 20 µg | $410.00 |
APOC1 encodes apolipoprotein C-I (apoC1), a small secreted apolipoprotein primarily associated with HDL and VLDL that modulates lipoprotein remodeling and receptor-mediated lipid transport. ApoC1 influences plasma triglyceride-rich lipoprotein metabolism by regulating interactions with lipoprotein receptors and lipases, thereby shaping cholesterol and triglyceride handling in hepatic and peripheral tissues. Through its roles in lipid trafficking and inflammatory signaling crosstalk, APOC1 is frequently studied in pathways linked to atherosclerosis, metabolic dyslipidemia, and macrophage biology. Altered APOC1 expression has also been investigated in neuroinflammatory contexts and tumor-associated myeloid programs where lipid metabolism supports cellular state changes.
apoC1 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the APOC1 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within APOC1. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt APOC1 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of APOC1-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.